Post/November 10, 2026Stargardt disease has no approved treatment. A new trial tests a shot that limits vitamin A reaching the eyeA Stargardt disease clinical trial has dosed its first participant with CITY-RBP4, a City Therapeutics shot meant to cut vitamin A delivery to the eye.HNHealthcare News·November 10, 2026
